Response to DHSC Coronavirus vaccine regulation consultation
We have submitted the following organisational response to the Distributing vaccines and treatments for COVID-19 and flu consultation run by the Department of Health and Social Care.
1. Temporary authorisation of the supply of unlicensed products
Noting that under normal circumstances vaccines and medications would need to undergo the requisite licensing processes that are detailed in the preamble of the consultation document, in the current climate there is a need to roll-out an effective mass vaccination programme at the earliest available opportunity. Recognising the tension between the benefits of rolling out a mass vaccination programme and the benefits that may bring versus the time it would take to undergo the licensing programme (which may identify unanticipated side effects of the vaccination), and the point made regarding the distinction between unlicensed and untested, on balance the proposed changes to the regulations are welcome in that they are aimed at reducing the exposure of civil liability to both the vaccine manufacturer and those that administer the vaccination (which include non-healthcare professionals on the general practice team). Any such authorisation should be communicated to practitioners including GPs and their teams directly, and via amendments to existing guidance in relation to prescribing unlicensed treatments, such as the GMC guidance here.
2. Civil liability and immunity
The issue with prescribing an unlicensed treatment or vaccine is that if an adverse incident ensues, it is unlikely that there will be any recourse to the manufacturer in relation to product liability (on the basis that the manufacturer will say that the treatment or vaccine was being used outside its licensed indication. The proposed changes to the regulations are welcome in that they are aimed at reducing the exposure of civil liability to both the vaccine manufacturer and those that administer the vaccination (which include non-healthcare professionals on the general practice team). Whilst we note that there are some limits to the extent of the immunity to civil liability but these are in the main directed at the manufacturer and do not seem to be unreasonable.
Given the unique circumstances under which the Covid vaccine may be brought into use, we welcome proposals to limit breach liability to parts of a supply chain which includes the person administering the product, rather than the chain in its entirety.
3. Proposed expansion to the workforce eligible to administer vaccinations
We agree that an expanded workforce is required to deliver a both the Covid and flu vaccination programmes and would highlight the fact that any person who administers any vaccination should have had adequate training and/or updating to cover the following as a minimum:
- An understanding of the mode of action and efficacy of the vaccine.
- Explaining the benefits and risks of the vaccine to patients.
- Explaining the potential side effects of the vaccine and what the patient should do if they occur.
- Safe vaccine administration (including the cold chain supply).
- How to manage immediate post vaccine complications (for example – fainting, anaphylaxis etc).
- Record-keeping.
- Aftercare.Vaccine promotion.
4. Vaccination promotion
N/A
5. Make provisions for wholesale dealing of vaccines
We welcome the proposal of providing an exemption from the need for a wholesale dealer’s licence to allow the swift and safe transfer of Covid-19 and flu vaccines to be made available to NHS organisations, NHS contracted service providers, and the medical services of the armed forces. For the avoidance of any doubt in relation to the contractual arrangements, we suggest that it would be helpful to specifically confirm that this would apply to Primary Care Networks, Federations and other general practice groups.
Last updated : 22 Sep 2020Londonwide Enterprise update (17 Aug 2016)
Practice managers conference and events Speakers have been confirmed for the Practice Manager Conference to be held at Woburn House on Thursday 22 September 2016. ‘Leadership through Change: making the...Patient engagement survey (17 Aug 2016)
We are asking for practices to share their experience of successfully developing their patient engagement work, including top tips, by completing our patient engagement surveys. These will help shape the...London Improvement Grant Fund 2017-18 (17 Aug 2016)
The London Improvement Grant Fund application process is now open. Practices need to submit their applications by 17:00 on Friday 30 September 2016 by emailing them to: England.LondonIGfund@nhs.net. Practices should...NHS England Update on Estates and Technology Transformation Fund (ETTF) (17 Aug 2016)
Unfortunately, information regarding submission dates for reimbursement claims for NHS England’s Estates and Technology Transformation Fund (ETTF) has caused some confusion. Please note that the submission date change is not related...New GPSoE Resources - Posters (16 Aug 2016)
We have produced two posters to help practices explain to patients and staff why we are in a state of emergency. One is for your waiting room and outlines the...Capita list cleanse plan (16 Aug 2016)
At the end of July it was reported that part of the new Primary Care Support Services contract between NHS England and Capita would include a list cleanse programme, designed...New requirements for hospitals re work with general practice (16 Aug 2016)
Londonwide LMCs’ CEO Dr Michelle Drage has written to Trust and Foundation Trust CEOs across London asking how they plan to implement the new requirements outlined in the 2016/17 NHS...General Practice Resilience Programme funding (16 Aug 2016)
£2.65m of resilience funding is available to London practices this financial year, as the Capital’s share of a £16m national pot, promised as part of the GP Forward View. This...TPP QRISK2 error – responsibility for practices (16 Aug 2016)
NHS England is concerned that only around half of practices affected by the TPP QRISK2 error have accessed the lists of affected patients provided to them. Dr Andrew Green,...Feedback on Capita Primary Care Support England services (16 Aug 2016)
Following concerns expressed about the current Capita/Primary Care Support England (PCSE) records and supplies services, the BMA recently sought feedback on practices’ experience of Capita’s service. Dan Hodgson in the...Guidance
We provide expert guidance for practices in our guidance section, as well as an archive of other materials you may find useful.
GP Support
Contact our GP Support team if you need help or advice.
The team provide professional and pastoral support to GPs and practice teams on a broad range of issues.